Distal humerus fractures are among the most common fractures of the upper extremity. They can be caused by a variety of factors, including falls, motor vehicle accidents, and sports-related injuries. Treatment of distal humerus fractures can be challenging due to the complex anatomy and the variety of fracture patterns. Traditional treatment of these fractures has been open reduction and internal fixation (ORIF) or external fixation. However, a new approach to treating distal humerus fractures has recently been developed, which involves arthroscopic-assisted ORIF. This new approach has been shown to be effective in the treatment of distal humerus fractures and offers several potential advantages over traditional methods.
The distal humerus is the end of the upper arm bone (humerus) closest to the elbow joint. It is composed of two main parts: the medial and lateral epicondyles. The medial epicondyle is located on the inner side of the humerus and is the attachment point for the elbow flexor muscles. The lateral epicondyle is located on the outer side of the humerus and is the attachment point for the elbow extensor muscles. The distal humerus is also the attachment point for several ligaments, including the medial collateral ligament and the lateral collateral ligament.
Distal humerus fractures can be classified into three main types: extra-articular, intra-articular, and comminuted. Extra-articular fractures involve only the bone and do not involve the joint. Intra-articular fractures involve both the bone and the joint, and can be further classified into several subtypes based on the location of the fracture. Comminuted fractures involve more than two fragments of bone and can be more difficult to treat.
Traditional treatment of distal humerus fractures involves either open reduction and internal fixation (ORIF) or external fixation. ORIF is a surgical procedure in which the fractured bone is realigned and held in place with plates, screws, and/or wires. External fixation involves the use of a frame or splint to hold the fractured bone in place while it heals. Both of these methods can be effective in treating distal humerus fractures, but each has its own advantages and disadvantages.
Arthroscopic-assisted ORIF is a new technique for treating distal humerus fractures that has recently been developed. This technique involves the use of arthroscopy to visualize the fracture and to assist in the reduction and fixation of the fracture. Arthroscopy is a minimally invasive procedure in which a small camera is inserted into the joint through a tiny incision. This allows the surgeon to better visualize the fracture and to reduce and fix it with more precision.
Arthroscopic-assisted ORIF offers several potential advantages over traditional methods of treating distal humerus fractures. First, it is a minimally invasive procedure that can reduce the risk of complications and speed up the recovery process. Second, it allows for better visualization of the fracture, which can improve the accuracy of the reduction and fixation. Finally, it can reduce the amount of soft tissue trauma, which can lead to improved outcomes.
Distal humerus fractures can be challenging to treat due to the complex anatomy and variety of fracture patterns. Traditional treatment of these fractures has been open reduction and internal fixation (ORIF) or external fixation. However, a new approach to treating distal humerus fractures has recently been developed, which involves arthroscopic-assisted ORIF. This new approach has been shown to be effective in the treatment of distal humerus fractures and offers several potential advantages over traditional methods.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation